¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦34Â÷ Ãá°èÇмú´ëȸ ¹× Á¦5Â÷ ÇÑÀÏ´ç´¢º´Æ÷·³ : 2021-05-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦34Â÷ Ãá°èÇмú´ëȸ ¹× Á¦5Â÷ ÇÑÀÏ´ç´¢º´Æ÷·³ : 2021-05-07
±³À°ÀÏÀÚ : 2021-05-07
±³À°Àå¼Ò : ¿Â¶óÀΠ 
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦34Â÷ Ãá°èÇмú´ëȸ ¹× Á¦5Â÷ ÇÑÀÏ´ç´¢º´Æ÷·³      
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 130,000¿ø      
ºñ°í Àü¹®ÀÇ È¸¿ø 80,000¿ø Àü¹®ÀǺñȸ¿ø 130,000¿ø Àü¹®ÀÇ¿Ü È¸¿ø 50,000¿ø Àü¹®ÀÇ¿Ü ºñȸ¿ø 100,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ09:00~09:30 Advanced insulin delivery devices (insulin patch pump, digital insulin pen)  ¹Úö¿µ(¼º±Õ°üÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ09:30~10:00 Application of CGM in inpatient setting including critical ill patients  ÁøÈï¿ë(ÀüºÏÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ10:00~10:30 Efficacy of CGM for type 2 diabetes  ·ùÇýÁø(°í´ëÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ10:30~11:00 Effect of the mobile phone-based systems for type 2 diabetes in primary care clinic settings  ¾ç¿©¸®(°¡Å縯ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ11:50~12:30 Insulin resistance: from the mechanism to therapeutic targets  ÃÖö¼ö(°¡ÃµÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ12:40~13:00 Role of SGLT2 inhibitor in cardio-renal continuum: what is the best time to take SGLT2i for T2D patients?  È«ÁØÈ­(À»ÁöÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ13:00~13:30 ´ç´¢º´ Ä¡·áÀÇ ½ÃÀÛ: Àν¶¸° °³¹ß À̾߱⠠À¯ÇüÁØ(CMº´¿ø) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ13:30~14:00 ´ç´¢º´ Ä¡·áÀÇ º¯È­: Àν¶¸° ÀÌÈÄÀÇ º¯È­  ¿øÁ¾Ã¶(ÀÎÁ¦ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ14:00~14:30 Çѱ¹ÀÎ ´ç´¢º´ Ä¡·áÀÇ ÇöÀç¿Í ¹Ì·¡: ÇöȲ°ú °úÁ¦  ±è´ëÁß(¾ÆÁÖÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ15:30~16:00 Is albuminuria a therapeutic target for diabetic kidney disease?  ¿À¼¼¿ø(°í·ÁÀÇ´ë ½ÅÀå³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ16:00~16:30 Glycemic control in patients with ESKD; should they be treated less intensively?  ±è¹Ì°æ(°è¸íÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ16:30~17:00 Is protein restriction effective on all diabetic patients with CKD?  À̼ö¹Ì(µ¿¾ÆÀÇ´ë ½ÅÀå³»°ú) 
±³À°½Ã°£ 05-07 ¿Â¶óÀΠ17:00~17:30 Is metformin bad for CKD in diabetic patients?  ÀÌÁ¤Ç¥(¼­¿ïÀÇ´ë ½ÅÀå³»°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦34Â÷ Ãá°èÇмú´ëȸ ¹× Á¦5Â÷ ÇÑÀÏ´ç´¢º´Æ÷·³ : 2021-05-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2021³â ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2021-05-07
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) 1Çбâ À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ (À̺ñÀÎÈÄ°ú º¸Çè µ¿Çâ) : 2021-05-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 25 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 25 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 31 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 28 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 26 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 19 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 7 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 7 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 14 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 11 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 5 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 17 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 9 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 19 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 12 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷